Issuer Newsroom

Gorgio International Holding

Wire Volume: 1 Disclosures

Corporate Disclosures & Press Wire (1)

From Personalised Cancer Vaccines to AI Diagnosis: How London Is Shaping Britain’s Next Wave of Cancer Care
LONDON, UK - September 25, 2026··Uncategorized

From Personalised Cancer Vaccines to AI Diagnosis: How London Is Shaping Britain’s Next Wave of Cancer Care

London is at the forefront of cancer research, focusing on personalised treatments and early diagnosis through innovations like personalised vaccines, AI, and molecular testing. NHS England London has launched a Life Sciences Strategy to facilitate the adoption of these medical innovations, aligning with a national plan aiming for improved cancer survival rates by 2035. While promising developments are underway, such as personalised cancer vaccines and AI diagnostics, these innovations must prov

Read disclosure →